Failure to achieve tight control of plasma cholesterol and apolipoprotein B with intraperitoneal insulin infusion in type 1 diabetes.
The best route of insulin administration by infusion pumps remains a subject of controversy. For that reason plasma lipids and apolipoproteins were compared in three groups of nine patients who had been treated for several months or years with conventional treatment (group I), continuous subcutaneous insulin infusion (CSII, group II) or continuous intraperitoneal insulin infusion (CPII, group III). Plasma cholesterol and apolipoprotein B remained increased on CPII compared with CSII even when similar satisfactory or even tight diabetic control was achieved with both techniques. This study suggests that cholesterol and perhaps apolipoprotein B biosynthesis by the liver is increased in patients treated with CPII compared to those treated with CSII.
Monnier
L H
LH
Department of Metabolism, Hôpital Lapeyronie, Montpellier, France.
Pares Herbute
N
N
Guastamacchia
E
E
Colette
C
C
Selam
J L
JL
Crastes de Paulet
P
P
Beraud
J J
JJ
Mirouze
J
J
D000328:Adult; D001055:Apolipoproteins B / Q000097:blood*; D001835:Body Weight; D002784:Cholesterol / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007332:Insulin Infusion Systems; D008297:Male; D014280:Triglycerides / Q000097:blood
D001055:Apolipoproteins B; D002784:Cholesterol; D006442:Glycated Hemoglobin; D014280:Triglycerides